Format

Send to

Choose Destination
Clin Chem. 2015 Oct;61(10):1235-40. doi: 10.1373/clinchem.2015.238105. Epub 2015 Aug 13.

Clopidogrel and CYP2C19: pharmacogenetic testing ready for clinical prime time?

Author information

1
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada;
2
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Clinical Biochemistry, University Health Network; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada; ediamandis@mtsinai.on.ca.
3
Director of Pharmacogenomics & Personalized Therapeutics, Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai School, New York, NY;
4
Professor of Medicine, Physiology and Pharmacology, and Oncology, Wolfe Medical Research, Chair in Pharmacogenomics, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada;
5
Program Director, Adult Interventional Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
PMID:
26272232
DOI:
10.1373/clinchem.2015.238105
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center